Risk factors for nosocomial COVID-19 in a French university hospital

被引:2
|
作者
Dinh, C. [1 ]
Gallouche, M. [1 ,2 ]
Terrisse, H. [1 ]
Gam, K. [1 ]
Giner, C. [2 ]
Nemoz, B. [3 ,4 ]
Larrat, S. [3 ]
Giai, J. [1 ,5 ]
Bosson, Jl [1 ,5 ]
Landelle, C. [1 ,2 ,6 ]
机构
[1] Grenoble Alpes Univ, CNRS, Grenoble INP, MESP TIM C UMR 5525, Grenoble, France
[2] Grenoble Alpes Univ Hosp, Infect Control Unit, Grenoble, France
[3] Grenoble Alpes Univ Hosp, Virol Lab, Grenoble, France
[4] Univ Grenoble Alpes, Inst Biol Structurale IBS, Antibodies & Infect Dis, CEA,CNRS, Grenoble, France
[5] Grenoble Alpes Univ Hosp, Publ Hlth Dept, Grenoble, France
[6] Pavillon E Chu Grenoble Alpes, Serv dHygiene Hosp, CS 10217, F-38043 Grenoble 9, France
来源
INFECTIOUS DISEASES NOW | 2023年 / 53卷 / 05期
关键词
COVID-19; Nosocomial infection; Risk factors; SARS-CoV-2; TRANSMISSION; SARS-COV-2; INFECTION; INFLUENZA; BACTERIAL;
D O I
10.1016/j.idnow.2023.104695
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: Prevention strategies implemented by hospitals to reduce nosocomial transmission of SARS-CoV-2 sometimes failed. Our aim was to determine the risk factors for nosocomial COVID-19.Patients and methods: A case-control study was conducted (September 1, 2020-January 31, 2021) with adult patients hospitalized in medical or surgical units. Infants or patients hospitalized in ICU were excluded. Cases were patients with nosocomial COVID-19 (clinical symptoms and RT-PCR + for SARS-CoV-2 or RT-PCR + for SARS-CoV-2 with Ct <= 28 more than 5 days after admission); controls were patients without infection (RT-PCR- for SARS-CoV-2 > 5 days after admission). They were matched according to length of stay before diagnosis and period of admission. Analyses were performed with a conditional logistic regression.Results: A total of 281 cases and 441 controls were included. In the bivariate analysis, cases were older (OR per 10 years: 1.22; 95%CI [1.10;1.36]), had more often shared a room (OR: 1.74; 95%CI [1.25;2.43]) or a risk factor for severe COVID-19 (OR: 1.94; 95%CI [1.09;3.45]), were more often hospitalized in medical units [OR: 1.59; 95%CI [1.12;2.25]), had higher exposure to contagious health care workers (HCW; OR per 1person-day: 1.12; 95%CI [1.08;1.17]) and patients (OR per 1 person-day: 1.11; 95%CI [1.08;1.14]) than controls. In an adjusted model, risk factors for nosocomial COVID-19 were exposure to contagious HCW (aOR per 1person-day: 1.08; 95%CI [1.03;1.14]) and to contagious patients (aOR per 1person-day: 1.10; 95%CI [1.07;1.13]).Conclusions: Exposure to contagious professionals and patients are the main risk factors for nosocomial COVID-19.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] SARS-CoV-2 nosocomial infection acquired in a French university hospital during the 1st wave of the Covid-19 pandemic, a prospective study
    Landoas, A.
    Cazzorla, F.
    Gallouche, M.
    Larrat, S.
    Nemoz, B.
    Giner, C.
    Le Marechal, M.
    Pavese, P.
    Epaulard, O.
    Morand, P.
    Mallaret, M. -R.
    Landelle, C.
    ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL, 2021, 10 (01)
  • [22] Risk Factors Associated with In-Hospital Mortality in Iranian Patients with COVID-19: Application of Machine Learning
    Shafiekhani, Sadjad
    Rafiei, Sima
    Abdollahzade, Sina
    Souri, Saber
    Moomeni, Zeinab
    POLISH JOURNAL OF MEDICAL PHYSICS AND ENGINEERING, 2022, 28 (01): : 19 - 29
  • [23] Clinical characteristics and risk factors associated with nosocomial COVID-19 infection in patients with hematological disorders in Japan
    Ohara, Shin
    Fujii, Takayuki
    Ide, Shiro
    Uchida, Tomoyuki
    Inoue, Morihiro
    Hagaihara, Masao
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2021, 114 (06) : 719 - 724
  • [24] Cutaneous Manifestations in Patients With COVID-19 Treated at a University Hospital in Southern Brazil
    Dupont, Leticia
    Duquia, Rodrigo P.
    Pizutti, Gustavo W.
    Nunes, Fernanda B.
    Branchini, Gisele
    Mosquera, Elsa Stella B.
    Bonamigo, Renan R.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (11)
  • [25] Clinical characteristics and risk factors associated with nosocomial COVID-19 infection in patients with hematological disorders in Japan
    Shin Ohara
    Takayuki Fujii
    Shiro Ide
    Tomoyuki Uchida
    Morihiro Inoue
    Masao Hagaihara
    International Journal of Hematology, 2021, 114 : 719 - 724
  • [26] Analysis of risk factors and the effect of specific treatments on the clinical outcome of patients hospitalized for COVID-19 at a university hospital in the Czech Republic
    Parizkova, R. Cerna
    Astapenko, D.
    Balik, M.
    Blazek, M.
    Dostal, P.
    Dusek, L.
    Fajfr, M.
    Jarkovsky, J.
    Jurisinova, I.
    Svobodova, E.
    Szanyi, J.
    Smahel, P.
    Cerny, V.
    ANESTEZIOLOGIE A INTENZIVNI MEDICINA, 2024, 35 (03): : 142 - 154
  • [27] Compassionate Use of Hydroxychloroquine in Clinical Practice for Patients With Mild to Severe COVID-19 in a French University Hospital
    Paccoud, Olivier
    Tubach, Florence
    Baptiste, Amandine
    Bleibtreu, Alexandre
    Hajage, David
    Monsel, Gentiane
    Tebano, Gianpiero
    Boutolleau, David
    Klement, Elise
    Godefroy, Nagisa
    Palich, Romain
    Itani, Oula
    Faical, Antoine
    Valantin, Marc-Antoine
    Tubiana, Roland
    Burrel, Sonia
    Calvez, Vincent
    Caumes, Eric
    Marcelin, Anne-Genevieve
    Pourcher, Valerie
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (11) : E4064 - E4072
  • [28] Two Waves of COVID-19 in University Setting: Mental Health and Underlying Risk Factors
    Kremenkova, Lucie
    Novotny, Jan Sebastian
    Kvintova, Jana
    FRONTIERS IN PSYCHOLOGY, 2021, 12
  • [29] Population Risk Factors for COVID-19 Mortality in 93 Countries
    Hashim, Muhammad Jawad
    Alsuwaidi, Ahmed R.
    Khan, Gulfaraz
    JOURNAL OF EPIDEMIOLOGY AND GLOBAL HEALTH, 2020, 10 (03) : 204 - 208
  • [30] COVID-19 Genetic and Environmental Risk Factors: A Look at the Evidence
    Abdelzaher, Hana
    Saleh, Basma M.
    Ismail, Hebatalla A.
    Hafiz, Marwa
    Gabal, Macy Abou
    Mahmoud, Miranda
    Hashish, Sarah
    Gawad, Rana M. Abdel
    Gharieb, Rami Y.
    Abdelnaser, Anwar
    FRONTIERS IN PHARMACOLOGY, 2020, 11